Harrow Health Inc (HROW) - Financial and Strategic SWOT Analysis Review

Harrow Health Inc (HROW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Harrow Health Inc (Harrow Health) formerly known as Imprimis Pharmaceuticals Inc, owns a portfolio of healthcare businesses which also includes ImprimisRx, the leading ophthalmology pharmaceutical compounding business in the US and holds large equity positions in Eton Pharmaceuticals, Melt Pharmaceuticals and Surface Pharmaceuticals. The company is focused on developing innovative medications for serve unmet needs. The company through its subsidiaries develops injectable Dropless Therapy formulations and topical LessDrops formulations. MAY-44 for treating dyspareunia and MAY-88 for treating interstitial cystitis and among others. Harrow Health is headquartered in Nashville, Tennessee, the US.

Harrow Health Inc Key Recent Developments

Dec 03,2020: Study on patented non-opioid MKO Melt reported in leading peer-reviewed anesthesia Journal
Oct 28,2020: Harrow Health announces resignation of Mr. Principi
Sep 30,2020: Harrow Health appoints Larry Van Horn to its board of directors
Aug 10,2020: Harrow Health publishes second quarter 2020 Letter to Stockholders
Jul 13,2020: Leading peer-reviewed journal publishes clinical study on ImprimisRxs combination prescription eyedrops

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Section 1 - About the Company
Harrow Health Inc - Key Facts
Harrow Health Inc - Key Employees
Harrow Health Inc - Key Employee Biographies
Harrow Health Inc - Major Products and Services
Harrow Health Inc - History
Harrow Health Inc - Company Statement
Harrow Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Harrow Health Inc - Business Description
Business Segment: Pharmaceutical Compounding
Overview
Performance
Business Segment: Pharmaceutical Drug Development
Overview
Performance
Harrow Health Inc - SWOT Analysis
SWOT Analysis - Overview
Harrow Health Inc - Strengths
Harrow Health Inc - Weaknesses
Harrow Health Inc - Opportunities
Harrow Health Inc - Threats
Harrow Health Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Harrow Health Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Dec 03, 2020: Study on patented non-opioid MKO Melt reported in leading peer-reviewed anesthesia Journal
Oct 28, 2020: Harrow Health announces resignation of Mr. Principi
Sep 30, 2020: Harrow Health appoints Larry Van Horn to its board of directors
Aug 10, 2020: Harrow Health publishes second quarter 2020 Letter to Stockholders
Jul 13, 2020: Leading peer-reviewed journal publishes clinical study on ImprimisRxs combination prescription eyedrops
Apr 01, 2020: Harrow Health receives loan under Paycheck Protection Program
Mar 24, 2020: ImprimisRx announces exclusive agreement with Doxy.me to provide healthcare professionals with telemedicine services
Mar 17, 2020: Harrow Health Appoints Teresa Sparks to its board of directors
Mar 12, 2020: ImprimisRx announces supply agreement with EyeCare Services Partners
Mar 09, 2020: ImprimisRx announces supply agreement with iOR Partners
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Harrow Health Inc, Key Facts
Harrow Health Inc, Key Employees
Harrow Health Inc, Key Employee Biographies
Harrow Health Inc, Major Products and Services
Harrow Health Inc, History
Harrow Health Inc, Subsidiaries
Harrow Health Inc, Key Competitors
Harrow Health Inc, Ratios based on current share price
Harrow Health Inc, Annual Ratios
Harrow Health Inc, Annual Ratios (Cont...1)
Harrow Health Inc, Annual Ratios (Cont...2)
Harrow Health Inc, Interim Ratios
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Harrow Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Harrow Health Inc, Performance Chart (2015 - 2019)
Harrow Health Inc, Ratio Charts
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review

Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Binx Health Inc - Product Pipeline Analysis, 2021 Update

Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its

USD 750 View Report

Aspira Womens Health Inc (AWH) - Financial and Strategic SWOT Analysis Review

Aspira Womens Health Inc (Aspira), formerly Vermillion Inc, is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available